5-amino-1mq and slu-pp-332 SLU2000 BAM15 Research Bundle slu pp 332 with 5

Specific clinical scenarios where injections are the standard of care include pernicious anemia, severe malabsorption syndromes, post-bariatric surgery when oral supplementation has failed, and critically low serum B12 levels accompanied by neurological deterioration

Clinical protocols show 200 mcg of each peptide provides BPC-157 Dosage Guide 2025 The recommended BPC-157 dosage ranges from 200-500 mcg daily, administered via subcutaneous injection for optimal healing and recovery

FDA reportedly granted GRAS status for one specific oral formulation but not for the injectable peptide

Very high doses may occasionally cause hypokalaemia (low potassium), particularly in patients with severe megaloblastic anaemia when treatment is initiated, necessitating monitoring in hospital settings